Mariantonia Carosi Selected Research

Mariantonia Carosi Research Topics

Disease

24	Neoplasms (Cancer) 10/2023 - 01/2010
10	Glioma (Gliomas) 03/2023 - 03/2009
7	Endometrial Neoplasms (Endometrial Cancer) 10/2023 - 01/2017
4	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 01/2010
4	Carcinoma (Carcinomatosis) 07/2018 - 04/2010
3	Mesothelioma 04/2024 - 01/2019
3	Breast Neoplasms (Breast Cancer) 09/2023 - 11/2017
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016 - 04/2010
2	Malignant Mesothelioma 04/2024 - 08/2021
2	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2017
2	Brain Neoplasms (Brain Tumor) 09/2023 - 01/2016
2	Ovarian Epithelial Carcinoma 01/2016 - 01/2016
2	Papillomavirus Infections 08/2012 - 10/2010
1	Clinical Deterioration 10/2023
1	Inflammation (Inflammations) 04/2022
1	Virus Diseases (Viral Diseases) 01/2021
1	Uterine Diseases (Endometrial Disease) 03/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Circulating Neoplastic Cells 11/2017
1	Seizures (Absence Seizure) 05/2017
1	Lymphoma (Lymphomas) 01/2016
1	Necrosis 01/2016
1	Epilepsy (Aura) 10/2012
1	Drug Resistant Epilepsy 10/2012
1	Squamous Intraepithelial Lesions 06/2011
1	Uterine Cervical Dysplasia 10/2010

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2010
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 04/2010
5	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 03/2023 - 10/2010
3	EnzymesIBA 04/2024 - 01/2018
3	Cell-Free Nucleic AcidsIBA 10/2023 - 01/2018
3	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 01/2010
3	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 01/2016
2	Histones (Histone)IBA 10/2023 - 04/2022
2	Syndecan-1 (Syndecan 1)IBA 09/2023 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2019
2	Bevacizumab (Avastin)FDA Link 05/2019 - 07/2018
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2019 - 07/2018
2	AntigensIBA 07/2018 - 01/2016
2	SteroidsIBA 05/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 04/2014 - 06/2011
2	fotemustine (Muphoran)IBA 11/2010 - 03/2009
1	Dehydroepiandrosterone (DHEA)IBA 04/2024
1	Androstenedione (4 Androstene 3,17 dione)IBA 04/2024
1	Hormones (Hormone)IBA 04/2024
1	AsbestosIBA 04/2024
1	ImmunosorbentsIBA 04/2024
1	Circulating Tumor DNAIBA 10/2023
1	Conditioned Culture MediaIBA 03/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	MethyltransferasesIBA 05/2022
1	O-(6)-methylguanineIBA 05/2022
1	AlpelisibIBA 01/2022
1	Estrogens (Estrogen)FDA Link 08/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 08/2021
1	Dinoprostone (PGE2)FDA Link 08/2021
1	Aromatase (CYP19)IBA 08/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	AntibodiesIBA 01/2021
1	LuciferasesIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 10/2019
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Cell Adhesion MoleculesIBA 07/2018
1	von Willebrand FactorIBA 07/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2017
1	PoisonsIBA 12/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	Lamin Type A (Lamin A)IBA 01/2017
1	Untranslated RNA (Noncoding RNA)IBA 01/2017
1	Transfer RNA (tRNA)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	PlatinumIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Retinoblastoma ProteinIBA 01/2016
1	SuspensionsIBA 01/2016
1	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2012
1	Subfamily B ATP Binding Cassette TransporterIBA 10/2012
1	multidrug resistance-associated protein 1IBA 10/2012
1	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2012
1	Indicators and Reagents (Reagents)IBA 04/2010

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2023 - 04/2010
5	Therapeutics 10/2023 - 04/2010
2	Radiotherapy 01/2019 - 01/2010
2	Neoadjuvant Therapy 06/2016 - 01/2016
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Chemoradiotherapy 05/2022
1	Salpingo-oophorectomy 10/2019
1	Hysterectomy 10/2019
1	Adjuvant Radiotherapy 10/2019
1	Immunotherapy 11/2017
1	Aftercare (After-Treatment) 04/2010